Status:
SUSPENDED
Cardiac Output Changes With Uterine Displacement
Lead Sponsor:
Brigham and Women's Hospital
Conditions:
Obstetric Anesthesia, Cardiac Monitoring
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
There is currently little information regarding the hemodynamic differences in uterine displacement techniques. Previous studies examining the hemodynamic effects of uterine displacement maneuvers hav...
Detailed Description
Aortocaval compression is a well-recognized physiologic concern in pregnancy. The gravid uterus can compress the inferior vena cava, impeding venous return and thereby reducing stroke volume and cardi...
Eligibility Criteria
Inclusion
- Healthy ASA physical status I-II
- Term parturient
Exclusion
- Woman in labor
- Presence of maternal medical conditions affecting the cardiovascular system (including preeclampsia, gestational hypertension)
- Fetal anomaly or intrauterine growth restriction (\< 25th percentile)
- Maternal renal or endocrine disease
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2023
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT02283931
Start Date
January 1 2015
End Date
December 30 2023
Last Update
August 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115